Search for: "Merck Sharpe & Dohme Corp" Results 21 - 40 of 135
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Oct 2021, 9:24 pm by Patent Docs
Ltd v Commissioner of Patents [2021] FCA 643, and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2021] FCA 947. [read post]
The Patentees filed two PTE applications, each of which was based on different goods on the ARTG: Brand Name OPDIVO® KEYTRUDA® Active ingredient nivolumab pembrolizumab Australian sponsor Bristol-Myers Squibb Australia Pty Ltd Merck Sharp & Dohme (Australia) Pty Ltd Relationship between sponsor and patentees Related to one of the patentees Not related to either patentee Date goods containing the drug were first included on ARTG 11 January 2016 16 April 2015… [read post]
25 Jun 2021, 4:15 am by Logan Murr
., Bristol-Myers Squibb Company, Corning Incorporated, and Merck Sharp & Dohme Corp. filed amicus briefs. [read post]
21 Jun 2021, 1:18 pm by Sean Wajert
  The Supreme Court discussed in Wyeth and later clarified in Merck Sharp & Dohme Corp. v. [read post]
26 May 2021, 8:40 pm by Adeline Chong
Written by Professor Yeo Tiong Min, SC (honoris causa), Yong Pung How Chair Professor of Law, Yong Pung How School of Law, Singapore Management University In Merck Sharp & Dohme Corp v Merck KGaA [2021] SGCA 14, a full bench of the Singapore Court of Appeal addressed the limits of transnational issue estoppel in Singapore law, and flagged possible fundamental changes to the common law on the recognition and enforcement of foreign judgments in… [read post]
24 Nov 2020, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit has taken the occasion, in appeals from the Patent Trial and Appeal Board as well as district courts, to remand judgments whenever the Court believes that the record below is devoid of sufficient detail to properly assess the correctness of the decisions made below (see "Merck Sharp & Dohme Corp. v. [read post]
9 Jun 2020, 9:56 am by Dennis Crouch
by Dennis Crouch Merck Sharp & Dohme Corp. v. [read post]
31 May 2020, 3:37 pm by Alex Woolgar
This time it was Merck KGaA v Merck Sharp & Dohme Corp and Ors [2020] EWHC 1273 (Ch), regarding issues remitted by the Court of Appeal back in November 2017 [fun fact: also the month that Salvator Mundi became the most expensive painting ever sold, at a cool $450,312,500.]Quick recap: Merck KGgA (Merck Global) is a German company that traces its roots back to 1668. [read post]
26 Nov 2019, 9:56 pm by Patent Docs
By Donald Zuhn -- Today, in Merck Sharp & Dohme Corp. v. [read post]
3 Sep 2019, 9:01 pm
The Four Courts, Dublin Author Jtdirl Released into public domain by the copyright owner Source Wikipedia Supreme Court of Ireland Jane Lambert Irish Supreme Court (Chief Justice Clarke and Justices O'Donnel Donal, McKechnie, Dunne, O'Malley and Iseult) Merck Sharp & Dohme Corp v Clonmel Healthcare Ltd. [read post]
26 Aug 2019, 12:09 pm
Supreme Court in the next term.Africa Correspondent Chijioke Okorie reports on Raconteur Productions Limited v Dioni VisionsEntertainment Limited and 2 Others, heard before the Lagos Division of the Federal High Court of Nigeria, concerning the possibility of copyright infringement of a ‘screenplay’, which is not specifically mentioned or defined in the Nigerian Copyright Act as a protected work.Platform Liability -Former GuestKat Mirko Brüß examines another case referred… [read post]
14 Aug 2019, 7:25 am
The AmeriKat hiding from work-relatedintruders in the Castello's gardenRight at the end of July, came big news from the Irish Supreme Court in Merck Sharp & Dohme Corp v Clonmel Healthcare Ltd 2019 IESC 65. [read post]
23 Jul 2019, 7:58 pm by Patent Docs
Merck Sharp & Dohme Corp., decided earlier this month, and as a bonus, illustrated how including disclosure in a specification for completeness and expanded claim scope can result in an invalidated claim when that scope unnecessarily encompasses the prior art. [read post]
25 Jun 2019, 2:00 am by Courtenay C. Brinckerhoff
Merck Sharp & Dohme Corp. may leave stakeholders in the pharmaceutical space scratching their heads, and highlights that it’s rarely possible to anticipate and avoid every claim construction issue that may be raised in a patent challenge. [read post]
19 Jun 2019, 8:26 am by Truc Nguyen and Ronald Meisburg
The Board’s recent decision in Merck, Sharp, & Dohme Corp., 367 NLRB No. 122 (May 7, 2019)  highlights the differences that can arise as a result of the collective bargaining process in the terms and conditions of employment for employers with a divided workforce of non-union and union-represented employees. [read post]